Betsy R LaPlant

Betsy R LaPlant

UNVERIFIED PROFILE

Are you Betsy R LaPlant?   Register this Author

Register author
Betsy R LaPlant

Betsy R LaPlant

Publications by authors named "Betsy R LaPlant"

Are you Betsy R LaPlant?   Register this Author

27Publications

815Reads

13Profile Views

Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia.

Expert Rev Hematol 2018 04 26;11(4):337-349. Epub 2018 Feb 26.

d Division of Hematology , Stanford University School of Medicine , Stanford , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1442716DOI Listing
April 2018

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II study.

Leuk Lymphoma 2016 07 24;57(7):1585-91. Epub 2015 Dec 24.

a Division of Hematology , Mayo Clinic , Rochester, NY , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1113280DOI Listing
July 2016

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma.

Am J Hematol 2010 May;85(5):320-4

Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420736PMC
May 2010